Brück, Oscar https://orcid.org/0000-0002-7842-9419
Sanmark, Enni
Ponkilainen, Ville
Bützow, Alexander
Reito, Aleksi
Kauppila, Joonas H.
Kuitunen, Ilari
Funding for this research was provided by:
University of Helsinki
Article History
Received: 19 July 2024
Accepted: 18 September 2024
First Online: 30 September 2024
Declarations
:
: A.B. declares being an employee of Krogerus Attorneys Ltd. (business law firm) and has assisted private and public clients in matters relating to the relevant legislation outside the submitted work. O.B. declares no competing non-financial interests but the following competing financial interests outside the submitted work: consultancy fees from Novartis, Sanofi, GSK, Astellas and Amgen; research grants from Pfizer and Gilead Sciences; and stock ownership (Hematoscope Oy). E.S. declares no competing non-financial interests but the following competing financial interests outside the submitted work: consultancy fees from Boehringer-Ingelheim, Pfizer and Orion, and research grants from Business Finland.